BiotechTube
Home/Hepion Pharmaceuticals/Timothy M. Block
TM

Timothy M. Block

Director

Hepion Pharmaceuticals

Therapeutic Areas

OncologyGastroenterology/Hepatology

Hepion Pharmaceuticals Pipeline

DrugIndicationPhase
mSEPT9 DNA Biomarker TestEarly Detection & Surveillance of Hepatocellular Carcinoma (HCC) in CirrhosisCommercialization / FDA Pathway
ctRNA Biomarker AssayEarly Diagnosis & Surveillance of Hepatocellular Carcinoma (HCC)Assay Development / Validation

Leadership Team at Hepion Pharmaceuticals

DK
Dr. Kaouthar Lbiati
Interim Chief Executive Officer
MP
Michael Purcell
Board Chair
View full Hepion Pharmaceuticals profile